JOYCE JOHNSON: Open Payments
NPI 1336598895 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,833 in 64 payments from 10 companies in 2025. Trend: 2023 $4,506 · 2024 $751 · 2025 $1,833
Food & beverage: $1,833
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 13 | $532 |
| Braeburn Inc. | 9 | $229 |
| Indivior Inc. | 5 | $224 |
| Axsome Therapeutics, Inc. | 4 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $159 |
| ABBVIE INC. | 13 | $155 |
| Janssen Pharmaceuticals, Inc | 2 | $143 |
| Alkermes, Inc. | 4 | $106 |
| Otsuka America Pharmaceutical, Inc. | 3 | $93 |
| Corium, LLC | 1 | $13 |
Products named: BRIXADI, SUBLOCADE, Auvelity, CAPLYTA, SPRAVATO, MAVYRET, REXULTI, VIVITROL.
Industry payments across KY — which companies pay providers there.
